Table 2 eConsults coded by question posed to specialist
From: Utility of eConsults for COVID-19 vaccine-related concerns in Ontario: a cross-sectional analysis
Reaction | Total (%) |
|---|---|
Pre-existing diagnosis of allergy to non-COVID-19 vaccine | 205 (41.1) |
Potential IgE-mediated allergic reactions | |
Other vaccines | 62 (12.4) |
Medications | 47 (9.4) |
Polyethylene glycol | 14 (2.8) |
Food | 14 (2.8) |
Radiocontrast media | 14 (2.8) |
Stinging insect | 1 (0.2) |
Other | 9 (1.8) |
Non-IGE-mediated allergic reaction | |
Type IV (Delayed) non-polyethylene glycol allergen | 5 (1.0) |
Type IV (Delayed) to polyethylene glycol | 0 (0.0) |
Other | 4 (0.8) |
Non-allergic reactions | |
Other vaccines | 35 (7.0) |
Pre-existing medical comorbidities | 74 (14.8) |
Immune-related | |
Autoimmune disease | 9 (1.8) |
Secondary immunodeficiency | 9 (1.8) |
Primary immunodeficiency | 3 (0.6) |
Immunosuppressive therapy | 2 (0.4) |
Pregnancy | 1 (0.2) |
Non-immune-related | |
Thromboembolic disease or hypercoagulability | 17 (3.4) |
Cutaneous conditions | 6 (1.2) |
Cancers | 0 (0.0) |
Other | 27 (5.4) |
Adverse Reaction to Dose 1 of COVID Vaccine | 180 (36.1) |
Potential IgE-mediated allergic reactions | |
Subjective or objective immediate angioedema, dyspnea, rashes, GI symptoms, or pre-syncope/syncope | 34 (6.8) |
Non-IgE-mediated allergic reaction | |
Delayed skin rashes | 54 (10.8) |
Other | 10 (2.0) |
Non-Allergic reaction | |
Neurological (Numbness, Tingling) | 27 (5.4) |
Delayed Flu-like Symptoms | 11 (2.2) |
Myocarditis | 3 (0.6) |
Other | 38 (7.6) |
Questions Regarding Potential Vaccine Exemption | 15 (3.0) |
Pediatric Age-Related Concerns | 1 (0.2) |
General Anxiety about COVID-19 Vaccination | 7 (1.4) |
Mixing of COVID-19 Vaccines | 0 (0.0) |
Administration-Related Concerns | 9 (1.8) |
Other | 8 (1.6) |
TOTAL | 499 |